Current patient management of chronic myeloid leukemia in Latin America-Reference-Cited by-同舟云学术

Current patient management of chronic myeloid leukemia in Latin America

Published:2010-07-21 Issue:21 Volume:116 Page:4991-5000
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cortes Jorge,De Souza Carmino,Ayala-Sanchez Manuel,Bendit Israel,Best-Aguilera Carlos,Enrico Alicia,Hamerschlak Nelson,Pagnano Katia,Pasquini Ricardo,Meillon Luis

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25273/fullpdf

Reference7 articles.

1. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood.,2006

2. The development of imatinib as a therapeutic agent for chronic myeloid leukemia;Deininger;Blood.,2005

3. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns;Kantarjian;Cancer.,2007

4. Therapeutic choices in patients with Ph1 (+) chronic myelogenous leukemia living in Mexico in the tyrosine kinase inhibitors (TKI) era: stem cell transplantation or TKI's?;Ruiz-Arguelles;Bone Marrow Transplant.,2008

5. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R);Kantarjian;Cancer.,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Molecular or Cytogenetic Response as a Favorable Prognostic Factor Before Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia;Transplantation and Cellular Therapy;2024-06

2. Polymorphisms in Drug Transporter and Metabolism Genes Associated with Resistance to Imatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis;Scientia Pharmaceutica;2023-12-25

3. Challenges in Chronic Myeloid Leukemia Management in South America;Current Hematologic Malignancy Reports;2021-10

4. The blue palate—A case series of imatinib-related oral pigmentation and literature review;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2021-01

5. Treatment patterns and deep molecular response in chronic phase – chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study;Leukemia & Lymphoma;2019-08-13